Vaccinia Virus (Lister Strain) Rabbit Polyclonal Antibody
CAT#: BP1076
Vaccinia Virus (Lister Strain) rabbit polyclonal antibody, Purified
Need it in bulk or conjugated?
Get a free quote
CNY 11,569.00
货期*
5周
规格
Cited in 6 publications. |
Product images
Specifications
Product Data | |
Applications | ELISA, IHC |
Recommend Dilution | ELISA. Immunohistochemistry (Protein K digestion is recommended with Formalin-Fixed Paraffin Embedded Sections). |
Reactivity | Vaccinia virus |
Host | Rabbit |
Clonality | Polyclonal |
Immunogen | Lister Strain (mixture of virions and infected cell polypeptides) |
Specificity | Recognizes purified virions. Does not cross-react with Parainfluenza (1-3), RSV, Adenovirus, Influenza A & B or HSV-1. Does not react with uninfected cells. Reactive with Lister, Wyeth, New York City and MVA strains of Vaccinia. |
Formulation | 0.01M PBS, pH 7.2 State: Purified State: Liquid purified Ig fraction (> 95% pure) Stabilizer: None Preservative: 0.09% Sodium Azide |
Concentration | 4-5 mg/ml (OD280 nm, E0.1% = 1.4) |
Purification | Protein A Chromatography |
Conjugation | Unconjugated |
Storage Condition | Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. |
Background | Vaccinia virus is an Orthopoxvirus, containing double stranded DNA. Fusion protein plays an important role in the entry of enveloped virus into cells. As vaccinia virus has a wide host range, it is conceivable that certain cellular components that are ubiquitously expressed on the cell mediate virus infection. The study of the entry process, attachment, fusion and the proteins and receptors involved is complex. During vaccinia virus infection, the fusion process is attributed to the action of the 14KDa protein (A27L). The N terminus of this protein recognises heparan sulfate on the cell surface. It interacts with the negative charges of sulfates of glycosaminoglycans (GAGs). Therefore, antibodies that recognize this 14KDa protein are able to neutralize vaccinia virus infection and enable identification other viral and cellular proteins which participate in the vaccinia virus entry process. |
Reference Data |
Citations (6)
The use of this Antibodies has been cited in the following citations: |
---|
Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice
,null,
Vaccines
,PubMed ID 37112626
|
Simplified Bioprinting-Based 3D Cell Culture Infection Models for Virus Detection
,null,
Viruses
,PubMed ID 33198291
|
Generation of recombinant MVA-norovirus: a comparison study of bacterial artificial chromosome- and marker-based systems
,Kugler, F;Drexler, I;Protzer, U;Hoffmann, D;Moeini, H;,
Virol. J.
,PubMed ID 31399106
[Vaccinia Virus]
|
Interference with SAMHD1 restores late gene expression of modified vaccinia virus Ankara (MVA) in human dendritic cells and abrogates type I interferon expression
,Sliva, K;Martin, J;von Rhein, C;Herrmann, T;Weyrich, A;Toda, M;Schnierle, BS;,
J. Virol.
,PubMed ID 31462561
[Vaccinia Virus]
|
Blocking development of a CD8+ T cell response by targeting lymphatic recruitment of APC
,Teoh D, Johnson LA, Hanke T, McMichael AJ, Jackson DG,
J. Immunol.
,PubMed ID 19201897
|
Identification and characterization of a phage display-derived peptide for orthopoxvirus detection
,Miller L, Michel J, Vogt G, DC6llinger J, Stern D, Piesker J, Nitsche A,
Anal Bioanal Chem
,PubMed ID 25311190
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
Customer
Reviews
Loading...